The Sarah Cannon Research Institute/Tennessee Oncology

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities	RET-altered Non Small Cell Lung Cancer; RET-altered Solid Tumors	Recruiting	Phase 1 / Phase 2	2026-08-19		NCT04683250
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Uveal Neoplasms, colonic disorder, colorectal cancer, colorectal neoplasm, cutaneous melanoma, digestive system disorder, digestive system neoplasm, eye disorder, intestinal disorder, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, ocular cancer, primitive neuroectodermal tumor, rectal disorder, skin disorder, skin neoplasm, uveal disorder, uveal melanoma	Recruiting	Phase 1 / Phase 2	2026-06-08		NCT03947385

Clinical trials